A role for immune response in the response to neoadjuvant chemotherapy for breast cancer patients

被引：0
|
作者：
Kim, R. [1 ]
Kawai, A. [1 ]
Wakisaka, M. [1 ]
Funaoka, Y. [1 ]
Yasuda, N. [1 ]
Ohtani, S. [2 ]
Ito, M. [2 ]
Arihiro, K. [3 ]
机构：
[1] Hiroshima Mark Clin, Dept Breast Surg, Hiroshima, Japan
[2] Hiroshima City Hosp, Dept Breast Surg, Hiroshima, Japan
[3] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30260-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P169
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [1] Metformin and response to neoadjuvant chemotherapy in patients with breast cancer
    Ghareeb, M.
    Naser, H.
    El-Gammal, M.
    Zeeneldin, A.
    Bahnacy, A.
    Khaled, H.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [2] Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Danzinger, Sabine
    Fuegerl, Alexandra
    Pfeifer, Christian
    Bernathova, Maria
    Tendl-Schulz, Kristina
    Seifert, Michael
    [J]. CANCER INVESTIGATION, 2021, 39 (6-7) : 457 - 465
  • [3] EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
    Atalay, Can
    Karaman, Niyazi
    Yilmaz, Kerim Bora
    Altinok, Mehmet
    [J]. JOURNAL OF BREAST HEALTH, 2007, 3 (01): : 26 - 30
  • [4] RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Solodyannikova, O.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S30 - S30
  • [5] Radionuclide evaluation of response to neoadjuvant chemotherapy in breast cancer patients
    Solodyannikova, O.
    Voit, N.
    Dzhuzha, D.
    Sukach, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S305 - S305
  • [6] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [7] Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer
    Kang, S. Y.
    Jung, Y. S.
    Kim, K. S.
    [J]. BREAST, 2011, 20 : S48 - S48
  • [8] The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients
    Ruiz, C
    Barros, A
    Motta, E
    Pinotti, J
    [J]. BREAST, 1997, 6 (05): : P949 - P949
  • [9] Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
    Tolaney, Sara M.
    Boucher, Yves
    Duda, Dan G.
    Martin, John D.
    Seano, Giorgio
    Ancukiewicz, Marek
    Barry, William T.
    Goel, Shom
    Lahdenrata, Johanna
    Isakoff, Steven J.
    Yeh, Eren D.
    Jain, Saloni R.
    Golshan, Mehra
    Brock, Jane
    Snuderl, Matija
    Winer, Eric P.
    Krop, Ian E.
    Jain, Rakesh K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (46) : 14325 - 14330
  • [10] The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer
    Arici, Serdar
    Karyagar, Sevda S.
    Karyagar, Savas
    Geredeli, Caglayan
    Cekin, Ruhper
    Secmeler, Saban
    Atci, Muhammed M.
    Sakin, Abdullah
    Cihan, Sener
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (06) : 1415 - 1420
12345